News Centres

Influx Healthtech expands its range to offer Liposomal Technology for Nutraceutical Brands

Liposomal Ingredients in Formulations Helps Brands Deliver Better Absorption, Better Outcomes, and Better Market Differentiation The nutraceutical industry is undergoing a significant transformation. Today’s consumers are more informed than ever and increasingly demand supplements that are not only safe and compliant, but also scientifically effective and visibly impactful. In response…
Read More

Influx Healthtech Ltd. announces “GLP-1 Support Nutrition” supplements for the new Semaglutide era in India

With the launch of Ozempic (semaglutide) in India, GLP-1 medicines have officially entered mainstream clinical practice for Type 2 diabetes management—bringing with them a big opportunity and a big responsibility: medication works best when nutrition is planned, not accidental. GLP-1 therapies are powerful because they help improve glycaemic control and…
Read More

Influx Healthtech Ltd Achieves FSSC 22000 Certification from NSF

Influx Healthtech Ltd is proud to announce its latest achievement — the FSSC 22000 certification awarded by NSF, a globally recognized certification body. This internationally acclaimed Food Safety System Certification is a strong validation of Influx’s commitment to food safety, hygiene, traceability, and quality management in its manufacturing processes. This…
Read More

Influx Healthtech Ltd Secures ₹1.2 Crore Repeat Export Order to Sudan via Octavius Pharma Pvt Ltd

Influx Healthtech Ltd, a leading CDMO (Contract Development and Manufacturing Organization) in the wellness and healthcare space, has received a significant repeat export order valued at approximately ₹1.2 crore from merchant exporter Octavius Pharma Pvt Ltd for the Sudanese market. This development marks yet another milestone in Influx’s growing global…
Read More

Influx Achieves FSSAI Form II Approval for Magnesium Glycinate

Influx Healthtech Ltd, has achieved a milestone by receiving the FSSAI Form II approval for the use of Magnesium Glycinate in tablet, capsule, and liquid preparations. This approval, granted by the FSSAI Scientific Committee, reinforces Influx Healthtech’s commitment to innovation and regulatory compliance. Magnesium Glycinate is a highly bioavailable form…
Read More

Influx Healthtech Ltd. Successfully Completes NBC Universal Social Audit for Disney-Approved Manufacturing

In a significant milestone underscoring its commitment to global quality and ethical standards, Influx Healthtech Ltd. has successfully completed the NBC Universal Social Audit, a mandatory compliance audit for manufacturers producing goods associated with Disney’s licensed properties. This achievement not only highlights Influx Healthtech’s robust manufacturing practices but also reinforces…
Read More